The Investor
09 Nov 2026, 19:23
AWS and Deerfield Management Partner to Accelerate AI Adoption Across Healthcare Portfolio
Amazon Web Services announced a collaboration with Deerfield Management aimed at accelerating the development and deployment of AI-native healthcare and life sciences companies.
Under the agreement, AWS will become a preferred AI provider for Deerfield and selected portfolio companies, giving them access to generative AI, cloud infrastructure and technical support for applications spanning drug discovery, operational automation and care delivery.
The partnership will combine AWS services with Deerfield Intelligence’s AI engineering capabilities and the broader innovation ecosystem at Cure, Deerfield’s New York healthcare innovation campus. Selected companies will also receive training in areas including large-scale model training, inference optimization and healthcare-focused managed services.
AWS highlighted services such as Amazon Bio Discovery and Amazon Bedrock AgentCore as tools that could support healthcare-specific AI applications and agentic systems at scale.
The collaboration also extends to Deerfield’s internal operations. Its Deerfield Intelligence and Deerfield Discovery and Development teams plan to use AWS technology in research, scientific evaluation and portfolio-company development.
One existing example is Ascertain, a Deerfield-backed healthcare technology company that uses AWS infrastructure for an agentic AI platform designed to automate complex clinical and administrative workflows, including case management and prior authorization.
The partnership strengthens AWS’s position in healthcare AI while giving Deerfield and its portfolio companies a broader infrastructure base for developing and scaling AI-driven clinical, research and operational products.
Amazon Web Services announced a collaboration with Deerfield Management aimed at accelerating the development and deployment of AI-native healthcare and life sciences companies.
Under the agreement, AWS will become a preferred AI provider for Deerfield and selected portfolio companies, giving them access to generative AI, cloud infrastructure and technical support for applications spanning drug discovery, operational automation and care delivery.
The partnership will combine AWS services with Deerfield Intelligence’s AI engineering capabilities and the broader innovation ecosystem at Cure, Deerfield’s New York healthcare innovation campus. Selected companies will also receive training in areas including large-scale model training, inference optimization and healthcare-focused managed services.
AWS highlighted services such as Amazon Bio Discovery and Amazon Bedrock AgentCore as tools that could support healthcare-specific AI applications and agentic systems at scale.
The collaboration also extends to Deerfield’s internal operations. Its Deerfield Intelligence and Deerfield Discovery and Development teams plan to use AWS technology in research, scientific evaluation and portfolio-company development.
One existing example is Ascertain, a Deerfield-backed healthcare technology company that uses AWS infrastructure for an agentic AI platform designed to automate complex clinical and administrative workflows, including case management and prior authorization.
The partnership strengthens AWS’s position in healthcare AI while giving Deerfield and its portfolio companies a broader infrastructure base for developing and scaling AI-driven clinical, research and operational products.
